Triamcinolone Acetonide Intravitreal Injection Shortage
Last Updated: December 9, 2020
Status: Resolved
Reason for the Shortage
-
- Novartis had Triesence on shortage due to manufacturing delays.
Available Products
-
- Triesence intravitreal suspension for injection, Novartis, 40 mg/mL, 1 mL vial, NDC 00065-0543-01
Estimated Resupply Dates
-
- Novartis has Triesence 40 mg/mL 1 mL vials fully available.
Updated
Updated December 9, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created September 27, 2019 by Rachael Freeman, PharmD, BCPS. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.